Bli medlem
Bli medlem

Du är här


aap: LOQTEQ® VA Distal Radius System has clinically proven and receives high level of market acceptance

aap Implantate AG / aap: LOQTEQ® VA Distal Radius System has clinically proven
and receives highlevel of market acceptance . Processed and transmitted by
Nasdaq Corporate Solutions.The issuer is solely responsible for the content
of this announcement.
* First polyaxial system in LOQTEQ® product family since one year successful
in the market

The evaluation following the market launch one year ago shows that the LOQTEQ®
VA Distal Radius System 2.5 fromaap
Implantate AG ("aap
") has clinically proven and enjoys a high level of market acceptance. Both
the implant and the related instruments meet with a positive response by
users and customers. The LOQTEQ® VA Distal Radius System 2.5 is the first
product in the LOQTEQ® VA (VA = Variable Angle) product family, which are
polyaxial implants that facilitate inserting angle-stable screws at different
angles. Polyaxial implants are required for treating areas such as the hand
that in surgery require both angle stability and flexibility in the insertion
of screws.

The LOQTEQ® VA Distal Radius System 2.5 was developed for the treatment of fractures of the distal radius (radius close to the wrist) and the distal ulna (ulna close to the wrist). Radius fractures account for about a quarter of all fractures. To meet patients' growing demands, a fast, mobilization-stable treatment with a permanent retention of the repositioning result is required. The special combination of anatomically preformed and small, angle-stable plates in conjunction with freely selectable screw angles and user-friendly instruments fulfils all the requirements of modern fracture management.
After already granted FDA approval the polyaxial radius system has been in use in the USA since this year as well and receives an especially high acceptance there. A sterilizing and a sieve system were developed specially for the U.S. market. Overall the wide range of plates in a compact set and specially developed instruments such as the screwdriver, co-designed by users, meet with a positive response. As radius fractures belong to the most frequent fractures the system is a sales driver.aap
will shortly be launching further polyaxial variants of different LOQTEQ® products for various anatomical areas in the market.

Implantate AG

Implantate AG is a globally operating medical device company headquartered in
Berlin, Germany. The company develops, manufactures and markets trauma
products for orthopaedics. The IP protected portfolio includes besides the
innovative anatomical plating system LOQTEQ® and trauma complementary
biomaterials a wide range of cannulated screws as well as standard plates and
screws. Furthermore,aap
Implantate AG has an innovation pipeline with promising development projects
as the antibacterial silver coating technology and magnesium based implants.
These technologies address critical problems in surgery that haven't yet been
resolved adequately. In German-speaking Europeaap
Implantate AG directly sells its products to hospitals, buying syndicates and
hospital groups while it uses a broad network of distributors in more than 25
countries at the international level.aap
Implantate AG's stock is listed in the Prime Standard segment of Frankfurt
Stock Exchange (XETRA: AAQ.DE). For more information, please visit, or download the Company's investor relations app from the Apple's
App Store or Google Play.

Forward-looking statement

This release may contain forward-looking statements based on current
experience, estimates and projections of the management board and currently
available information. They are not guarantees of future performance. Various
known and unknown risks, uncertainties and other factors could lead to
material differences between the actual future results, financial situation,
development or performance of the company and the estimates given here. Many
factors could cause the actual results, performance or achievements of aap to
be materially different from those that may be expressed or implied by such
statements. These factors include those discussed inaap
's public reports. Forward-looking statements therefore speak only as of the
date they are made.aap
does not assume any obligation to update the forward-looking statements
contained in this release or to conform them to future events or

For inquiries please contact:aap
Implantate AG, Fabian Franke, Investor Relations, Lorenzweg 5, 12099 Berlin,

Tel.: +49 30 7501 9-134, fax: +49 30 7501 9-290, e-mail: f.franke@aap


This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: aap Implantate AG via Globenewswire

Författare Hugin

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.